Newsletter Archive

1. 08.09.22 -- Solving Bioassay Challenges For Cell & Gene Therapies 8/9/2022
   08/09/22 Laboratory Network Newsletter
2. 07.26.22 -- Harnessing Lab Deviations For Performance Transformation In Vaccine Manufacturing 7/26/2022
   07/26/22 Laboratory Network Newsletter
3. 07.12.22 -- FDA Updates Guidance For Investigating OOS Test Results For Pharma Production 7/12/2022
   07/12/22 Laboratory Network Newsletter
4. 07.07.22 -- The Biotech Beatdown with Allan Shaw and New Hybrid Roles for Cell Therapy Clinical Trials -- Listen Now! 7/7/2022
   07/07/22 Laboratory Network Newsletter
5. 06.28.22 -- wNMR: Spectroscopy From Biomanufacturing To Point-Of-Care 6/28/2022
   06/28/22 Laboratory Network Newsletter
6. 06.14.22 -- New ICH Q14 Guidance Applies QbD To Analytical Procedures 6/14/2022
   06/14/22 Laboratory Network Newsletter
7. 06.08.22 -- New Episodes for You: Live Biologics & The Microbiome, Inside CAR-T Therapy for Ovarian Cancer and more. 6/8/2022
   06/08/22 Laboratory Network Newsletter
8. 05.24.22 -- FDA Seeks Public Comment On Quality Metrics Reporting Program 5/24/2022
   05/24/22 Laboratory Network Newsletter
9. 05.10.22 -- The Clinical Trial Sponsor's Roadmap To Avoid EMA (Cyber) Perdition 5/10/2022
   05/10/22 Laboratory Network Newsletter
10. 05.02.22 -- New Episodes: Allogeneic CAR-T Therapies, Antibodies for Severe Allergies, and more. 5/2/2022
    05/02/22 Laboratory Network Newsletter